Results 91 to 100 of about 2,176,861 (324)
Position statement : linear prurigo is a subtype of chronic prurigo
: Background Chronic prurigo (CPG) is a distinct disease characterized by chronic pruritus, history and/or signs of prolonged scratching and multiple pruriginous lesions.
Misery, L. +34 more
core
PRISMA 2020 flow diagram of included studies. ABSTRACT Purpose Immune checkpoint inhibitors have transformed treatment strategies for metastatic non‐small cell lung cancer (mNSCLC). This study aimed to assess the efficacy and safety of durvalumab combined with tremelimumab compared with those of standard chemotherapy, particularly in patients with low ...
Ikhwan Rinaldi +2 more
wiley +1 more source
Factors associated with pruritus uremic in chronic kidney failure patients [PDF]
Objective Uremic pruritus is one of the most distressing symptoms in patients with chronic renal failure. Interestingly, pruritus is not typically found in acute renal failure. Etiology and pathogenesis of uremic pruritus remain unclear.
Harlim, Ago
core +1 more source
Generalized chronic pruritus with fibromyalgia [PDF]
Max, Görg +3 more
openaire +2 more sources
Long‐term efficacy and safety of adjunctive cenobamate in a multinational Asian population. Open‐label extension (OLE) efficacy population included all patients who had taken ≥1 dose of study drug and had any seizure data during the OLE maintenance phase.
Sang Kun Lee +20 more
wiley +1 more source
Introduction Dupilumab and lebrikizumab have demonstrated efficacy in atopic dermatitis (AD) clinical trials; however, no direct comparisons exist. Methods Efficacy outcome achievement (dupilumab and lebrikizumab with topical corticosteroids [TCS]) at 16
Sonja Ständer +11 more
doaj +1 more source
Allergic contact dermatitis is a leading cause of occupational skin disease, with nickel(II) sulphate representing one of the most prevalent contact allergies worldwide.
Karoline Lukaschek +6 more
doaj +1 more source
Almost 50–90% of chronic kidney disease patients undergoing haemodialysis have been reported to have Chronic kidney disease-associated pruritus (CKD-aP).
Inayat Ur Rehman, Tahir Mehmood Khan
doaj +1 more source
PIEZO1 channels in cutaneous free nerve endings: novel insights into itch-scratch-mechanisms
Manuel Pedro Pereira +2 more
doaj +1 more source
ABSTRACT Objective Tofacitinib is a Janus kinase (JAK) inhibitor approved for the treatment of moderate‐to‐severe rheumatoid arthritis (RA). However, its synovium‐related molecular mechanisms, particularly its regulatory effect on fibroblast‐like synoviocyte (FLS) migration, remain incompletely understood.
Shuqi Fang +13 more
wiley +1 more source

